Brown D - Search Results

1

Phenoxodiol, an experimental anticancer drug, shows potent antiangiogenic properties in addition to its antitumour effects.

Gamble JR, Xia P, Hahn CN, Drew JJ, Drogemuller CJ, Brown D, Vadas MA. Gamble JR, et al. Among authors: brown d. Int J Cancer. 2006 May 15;118(10):2412-20. doi: 10.1002/ijc.21682. Int J Cancer. 2006. PMID: 16353157

2

Cytotoxic effects of the novel isoflavone, phenoxodiol, on prostate cancer cell lines.

Mahoney S, Arfuso F, Rogers P, Hisheh S, Brown D, Millward M, Dharmarajan A. Mahoney S, et al. Among authors: brown d. J Biosci. 2012 Mar;37(1):73-84. doi: 10.1007/s12038-011-9170-6. J Biosci. 2012. PMID: 22357205

3

Phenoxodiol protects against Cisplatin induced neurite toxicity in a PC-12 cell model.

Klein R, Brown D, Turnley AM. Klein R, et al. Among authors: brown d. BMC Neurosci. 2007 Aug 1;8:61. doi: 10.1186/1471-2202-8-61. BMC Neurosci. 2007. PMID: 17672914 Free PMC article.

4

Phenoxodiol-Topotecan co-administration exhibit significant anti-tumor activity without major adverse side effects.

Alvero AB, Brown D, Montagna M, Matthews M, Mor G. Alvero AB, et al. Among authors: brown d. Cancer Biol Ther. 2007 Apr;6(4):612-7. doi: 10.4161/cbt.6.4.3891. Cancer Biol Ther. 2007. PMID: 17457041

5

Anti-tumor activity of phenoxodiol: from bench to clinic.

Alvero AB, Kelly M, Rossi P, Leiser A, Brown D, Rutherford T, Mor G. Alvero AB, et al. Among authors: brown d. Future Oncol. 2008 Aug;4(4):475-82. doi: 10.2217/14796694.4.4.475. Future Oncol. 2008. PMID: 18684059 Review.

6

Polarised secretion of cytokines in primary human microvascular endothelial cells is not dependent on N-linked glycosylation.

Jurczyluk J, Brown D, Stanley KK. Jurczyluk J, et al. Among authors: brown d. Cell Biol Int. 2003;27(12):997-1003. doi: 10.1016/j.cellbi.2003.09.002. Cell Biol Int. 2003. PMID: 14642531

7

Phenoxodiol: pharmacology and clinical experience in cancer monotherapy and in combination with chemotherapeutic drugs.

Silasi DA, Alvero AB, Rutherford TJ, Brown D, Mor G. Silasi DA, et al. Among authors: brown d. Expert Opin Pharmacother. 2009 Apr;10(6):1059-67. doi: 10.1517/14656560902837980. Expert Opin Pharmacother. 2009. PMID: 19364253 Review.

8

Isometric Exercise Increases the Diameter of the Ascending Aorta in Youth with Bicuspid Aortic Valves.

Hartz J, Mansfield L, de Ferranti S, Brown DW, Rhodes J. Hartz J, et al. Among authors: brown dw. Pediatr Cardiol. 2022 Jun 30. doi: 10.1007/s00246-022-02946-5. Online ahead of print. Pediatr Cardiol. 2022. PMID: 35768732 Review.

9

Factors Associated with Increased Health-Related Quality of Life Benefits in Patients with Hereditary Transthyretin Amyloidosis with Polyneuropathy (ATTRv-PN) Treated with Inotersen.

Karam C, Brown D, Yang M, Done N, Dieye I, Bozas A, Vera Llonch M, Signorovitch J. Karam C, et al. Among authors: brown d. Muscle Nerve. 2022 Jun 29. doi: 10.1002/mus.27668. Online ahead of print. Muscle Nerve. 2022. PMID: 35766224

10

Single cell heterogeneity and evolution of breast cancer bone metastasis and organoids reveals therapeutic targets for precision medicine.

Ding K, Chen F, Priedigkeit N, Brown DD, Weiss K, Watters R, Levine KM, Heim T, Li W, Hooda J, Lucas PC, Atkinson JM, Oesterreich S, Lee AV. Ding K, et al. Among authors: brown dd. Ann Oncol. 2022 Jun 25:S0923-7534(22)01734-3. doi: 10.1016/j.annonc.2022.06.005. Online ahead of print. Ann Oncol. 2022. PMID: 35764274 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results